ClinicalTrials.gg
Status unknownNCT03255499Updated Nov 9, 2020

Efficacy of the MovinCog Intervention in Children

An interventional study of Exercise and Cognitive in Learning Disorders, Learning Disabilities and Cognitive Change, sponsored by University of Auckland, New Zealand. Status unknown at 1 site in New Zealand. Open to participants aged 7 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-09.

Sponsored by University of Auckland, New Zealand · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Nov 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
1,000
Allocation
Randomized
Ages
7 Years to 15 Years
Sex
All
01

Study summary

This study aims to test the efficacy of the MovinCog Intervention to enhance cognitive abilities in children 7-15 yrs. The intervention consists of two parts: a physical exercise regimen, based on high-intensity training, and a cognitive training component. The design will contrast the intervention with an active control group, matched for expectancy effects.

Read the detailed description

Specifically, the investigators will compare both components together (exercise and cognitive training) against either one of the components (exercise alone, or cognitive training alone) and against an active control group. The study will include measures of scholastic aptitude, as well as of working memory and cognitive control (primary outcome measures), two cognitive abilities that are critical to daily life activities, and that respond well to training. In addition, the investigators will measure physiological responses to training, to monitor changes associated with exercise (secondary outcome measures). Finally, the investigators will relate training-specific improvements with transfer gains, to better model the interaction between training and transfer. This will provide a comprehensive understanding of the dynamics associated with the intervention.

02

Conditions studied

  • Learning Disorders
  • Learning Disabilities
  • Cognitive Change

Keywords

  • cognitive training
  • physical exercise
  • brain dynamics
  • cognitive abilities
  • physiological markers
03

In context

Learning Disabilities

270 studies on the registry are indexed under Learning Disabilities; 62 are open to participants now.

This study's planned enrollment of 1,000 is above the median of 60 across 181 interventional studies indexed under Learning Disabilities.

Browse Learning Disabilities studies →

Lead sponsor

University of Auckland, New Zealand is the lead sponsor of 57 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 7-15

Exclusion criteria

Exclusion Criteria:

  • Age outside inclusion criteria
  • History of seizures, brain trauma
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
1,000 participants (estimated)

Study arms

  • Experimental
    Exercise and cognitive training

    This intervention includes a combination of high-intensity exercise (10min/day) and computerized cognitive training (20min/day). The software for the latter has been developed by our group, and includes 8 mini-games targeting different cognitive abilities. Both are developed for the MovinCog intervention. The intervention is personalized, based on individual performance.

    Behavioral: Exercise · Behavioral: Cognitive

  • Experimental
    Exercise

    High-intensity training regimen, 10min/day. Developed for the MovinCog intervention.

    Behavioral: Exercise

  • Experimental
    Cognitive training

    Computerized cognitive training, 20min/day. Developed for the MovinCog intervention.

    Behavioral: Cognitive

  • Active comparator
    Games

    The active control is composed of a blend of board games, computer games, and trivia quizzes. Specific content is personalized based on individual preferences, so as to reflect the flexibility of the experimental arms.

    Behavioral: Active control

Interventions

  • BehavioralExercise

    Exercise

  • BehavioralCognitive

    Cognitive

  • BehavioralActive control

    Active control, including a blend of computer games, board games, quizzes, trivia

06

What researchers measure

Primary outcomes

  1. Change from baseline working memory capacity at 10 weeks

    Constructs measured by multiple tasks (bds, corsi, n-back)

    Time frame: Baseline and 10-week posttest

  2. Change from baseline cognitive control at 10 weeks

    Constructs measured by multiple tasks (flanker, go/no-go, stroop)

    Time frame: Baseline and 10-week posttest

  3. Change from baseline scholastic aptitude at 10 weeks

    Constructs measured by multiple national (New Zealand), standardized tests

    Time frame: Baseline and 10-week posttest

Secondary outcomes

  1. Change from baseline resting heart rate at 10 weeks

    Measured by monitor

    Time frame: Baseline and 10-week posttest

  2. BDNF polymorphism measured by genetic saliva kit

    Effect of BDNF polymorphism on primary outcomes

    Time frame: Baseline

07

Study locations

1 site
  • University of Auckland
    Auckland, 1010, New Zealand
08

References and documents

Publications

  • Moreau D, Kirk IJ, Waldie KE. High-intensity training enhances executive function in children in a randomized, placebo-controlled trial. Elife. 2017 Aug 22;6:e25062. doi: 10.7554/eLife.25062. PubMed 28825973 ↗

Individual participant data

Plan to share: Yes — Release IPD at the time of publication.

Supporting information: Study protocol, Analytic code

Time frame: Post-publication

Access criteria: Unrestricted

Data sharing details ↗ · github.com

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03255499
Lead sponsor
University of Auckland, New Zealand
Responsible party
David Moreau (PhD, University of Auckland, New Zealand) — Principal investigator
First posted
Aug 21, 2017
Start date
Sep 10, 2017
Primary completion
Dec 31, 2021 (estimated)
Completion
Dec 31, 2021 (estimated)
Last update
Nov 9, 2020

Study contacts

David Moreau
principal investigator · University of Auckland, New Zealand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion